Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1130 (114th)

Chronic Kidney Disease Improvement in Research and Treatment Act of 2015

referredUnited States· United States Congress· EN

Introduced

26 February 2015

Last action

27 March 2015 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Marino, Tom [R-PA-10], Rep. Lewis, John [D-GA-5], Rep. Roskam, Peter J. [R-IL-6], Sen. Schiff, Adam B. [D-CA], Rep. Rangel, Charles B. [D-NY-15], Rep. LoBiondo, Frank A. [R-NJ-2], Rep. Higgins, Brian [D-NY-26], Rep. Clark, Katherine M. [D-MA-5], Rep. Brown, Corrine [D-FL-5], Rep. Kirkpatrick, Ann [D-AZ-2], Rep. Lofgren, Zoe [D-CA-18], Rep. Bustos, Cheri [D-IL-17], Rep. Heck, Joseph J. [R-NV-3], Rep. Thompson, Glenn [R-PA-15], Rep. Payne, Donald M., Jr. [D-NJ-10], Rep. Pocan, Mark [D-WI-2], Rep. Lujan Grisham, Michelle [D-NM-1], Rep. Rush, Bobby L. [D-IL-1], ROBERT BRADY, Rep. Hardy, Cresent [R-NV-4], Rep. Jolly, David W. [R-FL-13], Rep. Sanchez, Loretta [D-CA-46], Rep. Johnson, Henry C. "Hank" [D-GA-4], Rep. Esty, Elizabeth H. [D-CT-5], Rep. Lance, Leonard [R-NJ-7], Rep. Sánchez, Linda T. [D-CA-38], Rep. Honda, Michael M. [D-CA-15], Rep. Rice, Kathleen M. [D-NY-4], Rep. Cummings, Elijah E. [D-MD-7], Rep. Costello, Ryan A. [R-PA-6], Rep. Butterfield, G. K. [D-NC-1], Rep. Nolan, Richard M. [D-MN-8], Rep. Nugent, Richard B. [R-FL-11], Rep. Dold, Robert J. [R-IL-10], Rep. Barletta, Lou [R-PA-11], Rep. Pingree, Chellie [D-ME-1], Rep. Clarke, Yvette D. [D-NY-9], Rep. Beatty, Joyce [D-OH-3], Rep. Conyers, John, Jr. [D-MI-13], Rep. Scott, Austin [R-GA-8], Rep. Chaffetz, Jason [R-UT-3], Rep. Cartwright, Matt [D-PA-17], Rep. Grothman, Glenn [R-WI-6], Rep. Luetkemeyer, Blaine [R-MO-3], Rep. Herrera Beutler, Jaime [R-WA-3], Sen. Sinema, Kyrsten [I-AZ], Rep. Bishop, Sanford D. [D-GA-2], Rep. Smith, Christopher H. [R-NJ-4]

Subjects

Healthcare, Education

Source updated

5 December 2025

Healthcare · Education

Summary

Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 Amends title XVIII (Medicare) of the Social Security Act to revise Medicare payments for dialysis services provided to individuals with end stage renal disease (ESRD) and acute kidney injury. Extends the time period when a private health insurer, in determining benefits, cannot consider a group health insurance enrollee's ESRD or entitlement to Medicare coverage due to ESRD. Makes individuals with ESRD eligible for Medicare Advantage. Allows dialysis facilities to provide kidney disease education services and allows physician assistants, nurse practitioners, or clinical nurse specialists to refer individuals to those services. Requires the Department of Health and Human Services (HHS) to establish an ESRD Care Coordination program to provide higher Medicare payments to nephrologists, dialysis facilities, and other providers that reduce spending on ESRD by being part of a coordinated care organization. Amends the Public Health Service Act to include dialysis as a service provided by the National Health Service Corps in health professional shortage areas. Makes nephrologists and non-physician practitioners who provide dialysis eligible for the National Health Service Corps Scholarship Program and Loan Repayment Program. Requires the Government Accountability Office to submit a report identifying gaps in chronic kidney disease research and comparing research funding to expenditures on disease treatment. Requires HHS to study the causes of kidney disease and efforts to treat kidney disease in disproportionately affected minority populations.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 26 February 2015

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 26 February 2015

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 26 February 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 26 February 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 27 February 2015

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  6. 27 March 2015

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 26 February 2015

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 26 February 2015

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 26 February 2015

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 75 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.